Clinical Trials Logo

Clinical Trial Summary

Our study evaluates the efficacy of IGIV treatment in PPS on clinical (walking and pain) and isokinetic (muscle strength) criteria, on patients with PS at Montpellier's Hospital


Clinical Trial Description

Patients are admitted to a multidisciplinary consultation (neurologist, PMK) to validate the indication of treatment with IGIV. Realization of a pre-therapeutic evaluation in the department of MPR on the criteria of judgment, then the patient is admitted in a service of neurology to benefit from the cure of IGIV. The patient is then re-admitted to a PMR service for post-treatment evaluation.

Collection of data retrospectively. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04004390
Study type Observational
Source University Hospital, Montpellier
Contact
Status Completed
Phase
Start date June 28, 2019
Completion date December 30, 2019